(2R,3R,4R,5S,6R)-2-(4-BROMO-3-((4-((3R)-OXOLAN-3-YL)OXYPHENYL)METHYL)PHENYL)-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL
UNII R626G6K65M
Substance Identification & Data
This profile provides standardized clinical and technical data for (2r,3r,4r,5s,6r)-2-(4-bromo-3-((4-((3r)-oxolan-3-yl)oxyphenyl)methyl)phenyl)-6-(hydroxymethyl)oxane-3,4,5-triol, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R626G6K65M.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2452301-12-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C23H27BrO7 WETJYJMFYZMTCR-JEOSHJBNSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2r,3r,4r,5s,6r)-2-(4-bromo-3-((4-((3r)-oxolan-3-yl)oxyphenyl)methyl)phenyl)-6-(hydroxymethyl)oxane-3,4,5-triol. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.